Yu-dong T. Xiao

No. 139 Middle Renmin Rd
Changsha, 410011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma.

Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma.

Journal: Alimentary pharmacology & therapeutics

Published: December 10, 2025

Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study.

Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study.

Journal: Liver cancer

Published: September 21, 2025

Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204).

Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204).

Journal: Hepatology (Baltimore, Md.)

Published: July 13, 2025

High Fibroblast Activation Protein Expression in Hepatocellular Carcinoma: CT Imaging Features and Histological Characteristics.

High Fibroblast Activation Protein Expression in Hepatocellular Carcinoma: CT Imaging Features and Histological Characteristics.

Journal: Academic radiology

Published: March 04, 2025

Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma.

Skeletal muscle index/systemic immune-inflammation index (SMI/SII) ratio predicts prognosis in patients with hepatocellular carcinoma.

Journal: World journal of surgical oncology

Published: February 14, 2025

Analysis of the safety and efficacy of microwave ablation of several foci of multiple lung metastases from colorectal cancer.

Analysis of the safety and efficacy of microwave ablation of several foci of multiple lung metastases from colorectal cancer.

Journal: Frontiers in oncology

Published: November 04, 2024

Identification of proliferative hepatocellular carcinoma using the SMARS score and implications for microwave ablation.

Identification of proliferative hepatocellular carcinoma using the SMARS score and implications for microwave ablation.

Journal: Insights into imaging

Published: April 14, 2024

CD36-mediated accumulation of MDSCs exerts abscopal immunosuppressive responses in hepatocellular carcinoma after insufficient microwave ablation.

CD36-mediated accumulation of MDSCs exerts abscopal immunosuppressive responses in hepatocellular carcinoma after insufficient microwave ablation.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: March 21, 2024

Letter to the Editor: Intratumor fibrotic HCC, a subtype matching the Hoshida S1 subclass?

Letter to the Editor: Intratumor fibrotic HCC, a subtype matching the Hoshida S1 subclass?

Journal: Hepatology (Baltimore, Md.)

Published: November 27, 2023

Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection.

Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection.

Journal: Journal of hepatocellular carcinoma

Published: September 16, 2023

Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization.

Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization.

Journal: Radiology

Published: August 29, 2023

Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy.

Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy.

Journal: Biomedicines

Published: June 26, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026